Skip to main content
. 2019 Apr 5;43(3):793–802. doi: 10.1007/s00266-019-01361-1

Fig. 9.

Fig. 9

Patient with an oblong face before treatment (a), before treatment showing the treatment plan (b) and after the treatment (c). The treatment strategy was: hyaluronic acid: green circle: T1 (1.4 ml) for the temporal fossa using deep supraperiosteum injection with a high-density hyaluronic acid filler (VYC-20L). Gray circles: 1 = Ck 1, (0.2 ml), 2 = Ck 2 (0.4 ml), 3 = Ck 3 (0.6 ml) for the malar area in horizontal mode, using deep supraperiosteum injection with a high-density hyaluronic acid filler and Ck4 (1 ml) for the submalar area using subcutaneous injections with a medium-density hyaluronic acid filler. Blue circle: 1 = Jw 1 (0.2 ml) for the mandibular angle using deep supraperiosteum injection with a high-density hyaluronic acid filler. Purple figures: C1(1 ml) for the eversion of the chin and C6 (1 ml) for the prejowl area using a subcutaneous and deep injections with a high-density hyaluronic acid filler. The patient has provided a consent for using them in this publication